BioCryst Pharmaceuticals, Inc.
We develop oral small-molecule and protein therapeutics to treat hereditary angioedema (HAE) and other rare diseases.
608 employees · est. 1986 · Durham, United States
Elasmogen Ltd
To improve the outcomes and quality of life for people combating disease now, and in the future.
14 employees · est. 2016
BioCryst Pharmaceuticals, Inc. is the older company (1986 vs 2016); BioCryst Pharmaceuticals, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | BioCryst Pharmaceuticals, Inc. | Elasmogen Ltd |
|---|---|---|
| Founded | ||
| Founded | 1986 older | 2016 |
| Headquarters | ||
| Headquarters | Durham, United States | Not tracked yet |
| Employees | ||
| Employees | 608 larger | 14 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Debt | Series Unknown |
| Total Funding | ||
| Total Funding | $1.65B | $13.57M |
| Funding Rounds | ||
| Funding Rounds | 15 | 7 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Pharmaceuticals, Rare Diseases, Oral Therapeutics, Protein Therapeutics, Complement-mediated Diseases, Drug Design, Commercial-stage Biotech, US Headquarters, European Headquarters, Discovery Center Of Excellence, Structure-guided Drug Design, Global Presence, Biotech Research | Biologics, SoloMERs, Auto-inflammatory Diseases, Therapeutics, Ophthalmology, Oncology, Inflammatory Illnesses, Biologic Technology, Clinical Candidates, Immunotherapy, Drug Discovery, Patent Landscape, Innovation, Biotech Startups |
| Website | ||
| Website | biocryst.com | elasmogen.com |
About BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. is a global biotechnology company committed to enhancing the lives of individuals affected by complement-mediated and other rare diseases through the development of oral small-molecule and protein therapeutics. With a focus on structure-guided drug design, the company...
About Elasmogen Ltd
Elasmogen is a biotechnology startup founded in 2016, with a mission to improve outcomes and quality of life for individuals battling difficult-to-treat diseases. The company's focus lies in developing multi-functional therapeutic biologics utilizing its proprietary soloMER technology. This includes...
We will tell you when either one moves
BounceWatch watches BioCryst Pharmaceuticals, Inc. and Elasmogen Ltd for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at BioCryst Pharmaceutica... and Elasmogen Ltd — by email.
Frequently Asked Questions
Compare BioCryst Pharmaceuticals, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at BioCryst Pharmaceuticals, Inc. on 12 Sep 2024, and Elasmogen Ltd on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.